Young girl in rear seat child restraint

Child car seat

RESEARCH STUDY

IN-DEPTH STUDY OF CHILD CAR SEAT MATERIALS

Thank you for visiting NeuRA online, and for showing interest in the research we do here.

Who are we?
Neuroscience Research Australia is one of the largest research institutes in Australia dedicated to the study of the brain and nervous system. We have an international reputation for research excellence.

Areas of research include:

  • injury prevention
  • mental illness (e.g. schizophrenia, autism etc)
  • ageing and neurodegeneration (e.g. dementia)
  • sensation, movement, balance and falls
  • brain structure and function
  • neural injury
What is this research study about?

You are invited to take part in this research study. Our overall aim for this research project is to develop an evidence-based design guide for product information supplied with child restraint systems (car seats for children). To do this we are conducting two separate phases of studies about child restraints in cars. The first phase of focus groups will explore the use of current child restraint information materials and the second group involves consumer-testing to evaluate and enhance new materials.

To participate in this project you need to meet the following inclusion criteria:

  • Be over 18 years of age
  • Hold a current drivers licence
  • Conversant in English
Do I have to take part in this research study?

Participation in this research study is voluntary. If you don’t wish to take part, you don’t have to. Your decision will not affect your relationship with The University of New South Wales or Neuroscience Research Australia.

This Participant Information tells you about the research study. It explains the research tasks involved. Knowing what is involved will help you decide if you want to take part in the research.

If you decide you want to take part in this research project, you will be asked to:

  • Indicate your consent to be contacted by following the link to a screening survey
  • Do a quick screening survey which we will use to allocate you to one of the studies
What does participation in this research require, and are there any risks involved?

Once you register your interest, one of our researchers will contact you to give you more information about the studies we are conducting.

We will then invite you to participate in either a focus group or consumer-testing cycle. In the focus groups we will discuss your experience with child seats and child car seat information. Each group will run for approximately 1-2 hours. Participants will be reimbursed for their travel costs and provided with morning or afternoon tea.

If we ask you participate in the consumer-testing cycle, we will run an experiment in the lab and ask you to install a car seat. We will also ask you for feedback about the materials you used to do this.
Participation in any aspect of this study is completely voluntary and you can withdraw at any time!

Aside from giving up your time, we do not expect that there will be any risks or costs associated with taking part in this project.

Will I be paid to participate in this project?

You will be reimbursed for your time with a $25.00 voucher for your time.

What are the possible benefits to participation?

We hope to use information we get from this research study to benefit others who use child restraint systems by making the materials that are supplied with restraints easier to understand and thus safer for children.

What will happen to information about me?

By clicking on the survey link below and submitting the screening survey online you consent to the research team contacting you about participation in this study.

What if I want to withdraw from the research study?

If you do consent to be contacted and change your mind, you may withdraw at any time. You can ring the research team and tell them you no longer want to participate.

Submitting your completed questionnaire is an indication of your consent to be contacted and invited to participate in the study. You can withdraw your responses if you change your mind about having them included in the study, up to the point that we have analysed and published the results.

What should I do if I have further questions about my involvement in the research study?

The person you may need to contact will depend on the nature of your query. If you want any further information concerning this project or if you have any problems which may be related to your involvement in the project, you can contact the following members of the research team:

Research Team Contact

Name: Catherine Ho
Position: Research Assistant
Telephone: 02 9399 1848
Email: c.ho@neura.edu.au

Name: Alexandra Hall
Position: PhD Student
Telephone: 02 9399 1848
Email: a.hall@neura.edu.au

If you would like to participate in this study, please follow the link below and fill out our survey.

http://www.surveys.unsw.edu.au/f/161347/2303/

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

'I've got the best job for you dad. Your shaky arm will be perfect for it!'

Children… honest and insightful. Their innocence warms the heart. But what words do you use to explain to a child that daddy has an incurable brain disease? What words tell them that in time he may not be able to play football in the park, let alone feed himself? What words help them understand that in the later stages, dementia may also strike? Aged just 36, this was the reality that faced Steve Hartley. Parkinson's disease didn't care he was a fit, healthy, a young dad and devoted husband. It also didn't seem to care his family had no history of it. The key to defeating Parkinson's disease is early intervention, and thanks to a global research team, led by NeuRA, we're pleased to announce that early intervention may be possible. Your support, alongside national and international foundations Shake it Up Australia and the Michael J Fox Foundation, researchers have discovered that a special protein, found in people with a family history of the disease increases prior to Parkinson’s symptoms developing. This is an incredible step forward, because it means that drug therapies, aimed at blocking the increase in the protein, can be administered much earlier – even before symptoms strike. The next step is to understand when to give the drug therapies and which people will most benefit from it. But we need your help. A gift today will support vital research and in time help medical professionals around the world treat Parkinson’s disease sooner, with much better health outcomes. Thank you, in advance, for your support.  
APPEAL